drugset / Trial / NCT00826228
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
Phase 4
Completed
12 enrolled
Thomas J. Schnitzer
Eli Lilly and Company · collabShirley Ryan AbilityLab · collab
NaSingle-groupOpen-labelTreatment
Summary
Individuals with spinal cord injury sustain significant loss of bone mass in their lower extremities (20-40% or more). This study evaluates the ability of PTH and weight-bearing, two interventions that build bone, to increase bone mass in this population.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-03
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |